David Rolfe - Wedgewood Partners
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
← All TEVA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2012 Q2 | 0 | 0.00 | Sell 100.00% | 7.94 | $37.40–46.38 · VW $41.56i | SEC | |
| 2012 Q1 | 1,177,319 | 7.94 | Add 37.06% | 2.15 | $42.60–46.65 · VW $45.01i | $53,050,000 | SEC |
| 2011 Q4 | 858,982 | 7.32 | Add 12.22% | 0.80 | $36.88–46.33 · VW $42.78i | $34,669,000 | SEC |
| 2011 Q3 | 765,417 | 5.66 | Add 4.32% | 0.23 | $35.00–45.01 · VW $40.29i | $28,488,000 | SEC |
| 2011 Q2 | 733,717 | 5.62 | Add 82.45% | 2.54 | $45.21–51.15 · VW $47.67i | $35,218,000 | SEC |
| 2011 Q1 | 402,139 | 3.45 | Buy | 3.45 | $44.86–56.34 · VW $48.98i | $20,175,000 | SEC |
Price snapshot:
Current price$32.18
52-week low$14.99
52-week high$37.35